Skip to main content

Astrana Health, Inc.

For the period ended Mar 31, 2026. Filed May 8, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 8, 2026

ASTH$34.50-11.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2026

OR

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___.

Commission File No.001-37392

(Exact name of registrant as specified in its charter)

Delaware95-4472349
(State or Other Jurisdiction(I.R.S. Employer
of Incorporation or Organization)Identification Number)

1668 S. Garfield Avenue,2 nd Floor, Alhambra, California 91801

(Address of principal executive offices and zip code)

(626)282-0288

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each ClassTrading SymbolName of Each Exchange on Which Registered
Common Stock, $0.001 par value per shareASTHThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.☒ Yes ☐No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).☒ Yes ☐No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer☒Accelerated filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).☐Yes☒ No

As of May 4, 2026, there were 55,716,220 shares of common stock of the registrant, $0.001 par value per share, issued and outstanding, which includes 6,132,802 treasury shares that are owned by Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (“APC”), a consolidated affiliate of Astrana Health, Inc. These shares are legally issued and outstanding but treated as treasury shares for accounting purposes.

INDEX TO FORM 10-Q FILING

TABLE OF CONTENTS

PAGE
Glossary3
Introductory Note4
Note About Forward-Looking Statements4
PART I
ITEM 1Condensed Consolidated Financial Statements6
Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 20256
Condensed Consolidated Statements of Income for the three months ended March 31, 2026 and 20257
Condensed Consolidated Statements of Mezzanine Deficit and Stockholders’ Equity for the three months ended March 31, 2026 and 20258
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 20259
Notes to Condensed Consolidated Financial Statements10
ITEM 2Management’s Discussion and Analysis of Financial Condition and Results of Operations37
ITEM 3Quantitative and Qualitative Disclosures about Market Risk48
ITEM 4Controls and Procedures48
PART II
ITEM 1Legal Proceedings49
ITEM 1ARisk Factors49
ITEM 2Unregistered Sales of Equity Securities and Use of Proceeds50
ITEM 3Defaults Upon Senior Securities50
ITEM 4Mine Safety Disclosures50
ITEM 5Other Information50
ITEM 6Exhibits51
SIGNATURES53
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.